Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.transci.2024.104025 | DOI Listing |
Pulm Ther
January 2025
MSc Program in Sleep Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
The coexistence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) in the same patient is referred to as overlap syndrome (OS). Patients with OS suffer more frequently from cardiovascular disease (CVD) and carry a higher risk of COPD-related exacerbations than patients with COPD alone, especially when OSA is left untreated. Based on recent evidence, triple therapy, namely inhaled corticosteroid/long-acting muscarinic antagonist/long-acting beta-agonist (ICS-LABA-LAMA), is a treatment strategy in COPD patients with a history of exacerbations and/or CVD comorbidity.
View Article and Find Full Text PDFInflamm Bowel Dis
January 2025
University Centre for Research and Development Department of Pharmaceutical Sciences, Chandigarh University Gharuan, Mohali, Punjab, India.
J Nutr Health Aging
November 2024
Herbert Wertheim School of Public Health & Human Longevity Science, University of California San Diego, La Jolla, CA, United States. Electronic address:
JACC Adv
November 2024
Department of Cardiovascular Disease, Inova Schar Heart and Vascular, Falls Church, Virginia, USA.
JACC Adv
November 2024
Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!